General Information of Drug (ID: DM2SNXB)

Drug Name
N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl) Drug Info
Synonyms
N-(R-CARBOXY-ETHYL)-ALPHA-(S)-(2-PHENYLETHYL); Inhibitor 1; IH4; AC1LCW3V; DB02505; methyl 2-[4-[4-[[[1-(1H-imidazol-2-ylmethyl)piperidin-4-yl]-(4-pentylbenzoyl)amino]methyl]phenyl]phenyl]acetate; methyl 2-{4-[4-({N-[1-(1H-imidazol-2-ylmethyl)piperidin-4-yl]-1-(4-pentylphenyl)formamido}methyl)phenyl]phenyl}acetate; methyl [4'-({[1-(1H-imidazol-2-ylmethyl)piperidin-4-yl][(4-pentylphenyl)carbonyl]amino}methyl)biphenyl-4-yl]acetate
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
657149
TTD Drug ID
DM2SNXB

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Discontinued Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
US9353089, 135 DMWG98Z N. A. N. A. Patented [2]
US9353089, 330 DMK02LS N. A. N. A. Patented [2]
US9353089, 327 DMB4MJ0 N. A. N. A. Patented [2]
Pepstatin DM9S1EA Malaria 1F40-1F45 Terminated [3]
Leupeptin DMU075F Malaria 1F40-1F45 Investigative [3]
E-64 DMMOPAK Discovery agent N.A. Investigative [4]
KNI-10006 DMMISH6 Discovery agent N.A. Investigative [5]
PS-777621 DM3F7SD Discovery agent N.A. Investigative [6]
PS-662477 DMT4YFR Discovery agent N.A. Investigative [7]
KNI-10740 DMPWY6H Discovery agent N.A. Investigative [5]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Plasmodium Plasmepsin 2 (Malaria PLA2) TTXMNHO PLM2_PLAFA Inhibitor [1]

References

1 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
2 Compositions and methods for the treatment of malaria. US9353089.
3 Novel molecular targets for antimalarial chemotherapy. Int J Antimicrob Agents. 2007 Jul;30(1):4-10.
4 Antimalarial synergy of cysteine and aspartic protease inhibitors. Antimicrob Agents Chemother. 1998 Sep;42(9):2254-8.
5 Improvement of both plasmepsin inhibitory activity and antimalarial activity by 2-aminoethylamino substitution. Bioorg Med Chem Lett. 2010 Aug 15;20(16):4836-9.
6 High antiplasmodial activity of novel plasmepsins I and II inhibitors. J Med Chem. 2006 Dec 14;49(25):7440-9.
7 Identification of potent inhibitors of Plasmodium falciparum plasmepsin II from an encoded statine combinatorial library. Bioorg Med Chem Lett. 1998 Sep 8;8(17):2315-20.